James Latham plc (LON:LTHM – Get Free Report) shares crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,314.71 ($16.59) and traded as low as GBX 1,175 ($14.83). James Latham shares last traded at GBX 1,176.60 ($14.85), with a volume of 17,234 shares trading hands.
James Latham Price Performance
The company has a market capitalization of £238.69 million, a PE ratio of 1,040.71 and a beta of 0.83. The company’s 50 day moving average is GBX 1,303.29 and its two-hundred day moving average is GBX 1,314.34. The company has a quick ratio of 2.52, a current ratio of 5.43 and a debt-to-equity ratio of 4.30.
James Latham Cuts Dividend
The business also recently announced a dividend, which will be paid on Friday, January 24th. Investors of record on Thursday, January 2nd will be paid a dividend of GBX 7.95 ($0.10) per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a yield of 0.62%. James Latham’s payout ratio is 3,008.85%.
James Latham Company Profile
James Latham plc, together with its subsidiaries, engages in the importing and distribution of timber, panels, and decorative surfaces in the United Kingdom, the Republic of Ireland, rest of Europe, and internationally. The company offers panels, melamine, veneer, laminates, washroom collection, solid surface products, door blanks, plastics, hardwoods, engineered timber products, softwoods, flooring products, decking and timber cladding products, modified timbers and panels, fire retardant panels, advanced technical panels, and treatments, as well as architectural moldings and components.
Further Reading
- Five stocks we like better than James Latham
- How to Effectively Use the MarketBeat Ratings Screener
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Find Undervalued Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for James Latham Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for James Latham and related companies with MarketBeat.com's FREE daily email newsletter.